Form 8-K - Current report:
SEC Accession No. 0000950170-25-090205
Filing Date
2025-06-26
Accepted
2025-06-26 08:54:52
Documents
10
Period of Report
2025-06-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sndx-20250624.htm   iXBRL 8-K 40747
  Complete submission text file 0000950170-25-090205.txt   145209

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sndx-20250624.xsd EX-101.SCH 24852
12 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20250624_htm.xml XML 4682
Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 251075229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)